Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

Omrix Biopharmaceuticals, Inc. · New York, NY United States

Company Description

1120 Avenue of Americas
New York, NY
10036
United States (Map)
Phone: 212-887-6500
Fax: 212-887-6550
    Omrix Biopharmaceuticals helps keep blood in its place in the operating room. The company develops biosealants derived from human plasma to control bleeding during surgical procedures. The biosealants contain naturally occurring proteins that clot and adhere to tissue. Johnson & Johnson's Ethicon subsidiary markets and distributes these products under the names Evicel in the US and Quixil in Europe. Omrix's Evithrom thrombin product was developed with Ethicon primarily for neurosurgery. The FDA has approved both for hemostasis (minimizing blood loss) during surgery. Omrix was acquired by Johnson & Johnson in 2008 and became part of the Ethicon division. To read the full description, subscribe now.
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

    Key Omrix Biopharmaceuticals, Inc. Financials

    Company TypeSubsidiary

    Single Location
    Fiscal Year-EndDecember
    Employees212

    Omrix Biopharmaceuticals, Inc. Executives

    15 executives listed for Omrix Biopharmaceuticals, Inc.'s New York, NY location.
    TitleName & BioContact
    ChairmanLarry EllbergerNetwork
    CEO and DirectorRobert TaubNetwork
    President and COONissim MashiachNetwork

    Competition

    Competitive Landscape for Omrix Biopharmaceuticals, Inc.
    Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior products. Large companies have economies of scale in manufacturing and R&D. Small companies can compete successfully by specializing in a particular market segment, or through technical innovation. To read the full description, subscribe now.
    Top Omrix Biopharmaceuticals, Inc. Competitors
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!